Acta médica portuguesa (Acta Med Port)

Publisher: Ordem dos Médicos (Portugal); SPARC (Organization), Ordem dos Médicos

Current impact factor: 0.36

Impact Factor Rankings

2016 Impact Factor Available summer 2017
2014 / 2015 Impact Factor 0.36
2013 Impact Factor 0.281
2012 Impact Factor 0.151
2011 Impact Factor 0.091
2010 Impact Factor 0.256

Impact factor over time

Impact factor

Additional details

5-year impact 0.37
Cited half-life 4.50
Immediacy index 0.17
Eigenfactor 0.00
Article influence 0.09
Website Acta Medica Portuguesa website
Other titles Acta médica portuguesa (Online), Acta médica portuguesa
ISSN 0870-399X
OCLC 265249556
Material type Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Ordem dos Médicos

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author cannot archive a post-print version
  • Conditions
    • Publisher's version/PDF must be used
    • On Institutional Repositories
    • Applies to Acta Médica Portuguesa
    • RoMEO information provided by Blimunda Project
  • Classification

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Since their introduction in medical therapy, in the last quarter of the 20th century, monoclonal antibodies have gained an increasing importance in the treatment of various diseases. Neurology has been one of the medical specialties benefiting of the therapeutic potential of these monoclonal antibodies and certain neurological conditions may now contain such drugs in their therapeutic algorithms. Multiple sclerosis is one of these diseases and, in addition to the monoclonal antibodies already licensed for clinical use, several others are in development for future utilization in this specific area. The future will certainly pass through this kind of drugs and, in this article, a review of the most relevant data related to monoclonal antibodies already in use and also in clinical development for multiple sclerosis treatment will be performed.
    No preview · Article · Oct 2015 · Acta médica portuguesa
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Mediterranean spotted fever, an ancient zoonotic disease raising current issues. This study aims to reevaluate the disease clinical picture and to identify prognostic factors related to severe disease. Material and Methods: We evaluate cases admitted to a central hospital during 12-year period. The risk factors were determined by uni and multivariate analysis, comparing patients admitted in general infirmary versus intermediate/intensive care units or in case of death. Results: We reviewed 71 cases of Mediterranean spotted fever. The mean age was 63.3 ± 16.7 years and 52.1% were male. The eschar was observed in 62.0%. Fever and rash were the most common clinical findings. Forty five percent of patients developed complications and 22.5% were admitted to intermediate and/or intensive care units. Apyrexia, dyspnea, renal failure and elevated lactic dehydrogenase levels at admission were predictors of severe disease development (p < 0.034). Alcoholism was related with prolonged hospitalization (p = 0.020). Absence of fever (p = 0.019) and elevated serum creatinine levels (p = 0.028) were identified as independent factors associated with severe outcome. The mortality rate was 2.8%. Discussion: Although Mediterranean spotted fever is usually assumed to be benign, severe cases are emerging. Conclusion: Early identification of the infection and continuous patient surveillance are crucial, particularly in those with greater risk of developing severe or fatal disease.
    No preview · Article · Sep 2015 · Acta médica portuguesa